Impact of unbalanced karyotypes at diagnosis on prognosis of CML.

被引：0

作者：

Hehlmann, Ruediger

Kalmanti, Lida

Dietz, Christian

Lauseker, Michael

Haferlach, Claudia

Schlegelberger, Brigitte

Jotterand, Martine

Mueller, Martin C.

Haenel, Mathias

Koehne, Claus-Henning

Goebeler, Maria-Elisabeth

Pfreundschuh, Michael

Balleisen, Leopold

Burchert, Andreas

Krause, Stefan W.

Pfirrmann, Markus

Hasford, Joerg

Hochhaus, Andreas

Saussele, Susanne

Fabarius, Alice

机构：

[1] Heidelberg Univ, Med Fak Mannheim, Mannheim, Germany

[2] Univ Munich, Inst Med Informat Verarbeitung Biometrie & Epidem, Munich, Germany

[3] MLL, Munich, Germany

[4] Hannover Med Sch, Inst Zell & Mol Pathol, D-30623 Hannover, Germany

[5] Serv Genet Med, Lausanne, Switzerland

[6] Klinikum Chemnitz, Innere Med Klin 3, Chemnitz, Germany

[7] Klinikum Oldenburg, Klin Onkol & Hamatol, Oldenburg, Germany

[8] ZIM, Med Klin 2, Wurzburg, Germany

[9] Univ Klinikum Saarlandes, Homburg, Saar, Germany

[10] Evangel Krankenhaus Hamm, Hamatol Onkol Abt, Hamm, Germany

[11] Univ Klinikum Giessen & Marburg GmbH, Standort Marburg, Marburg, Germany

[12] Univ Klinikum Erlangen, Med Klin 5, Erlangen, Germany

[13] Univ Klinikum Jena, Jena, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7041

引用

页数：1

共 50 条

[1] Impact of unbalanced major and minor route karyotypes at diagnosis on prognosis of CML
Dietz, C. T.
Kalmanti, L.
Fabarius, A.
Lauseker, M.
Haferlach, C.
Schlegelberger, B.
Jotterand, M.
Mueller, M. C.
Haenel, M.
Koehne, C-H
Goebeler, M. -E
Pfreundschuh, M.
Balleisen, L.
Burchert, A.
Krause, S. W.
Edinger, M.
Pfirrmann, M.
Hasford, J.
Hochhaus, A.
Saussele, S.
Hehlmann, R.
Oncology Research and Treatment, 2015, 38 : 181 - 181
[2] Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
Fabarius, Alice
Kalmanti, Lida
Dietz, Christian T.
Lauseker, Michael
Rinaldetti, Sebastien
Haferlach, Claudia
Goehring, Gudrun
Schlegelberger, Brigitte
Jotterand, Martine
Hanfstein, Benjamin
Seifarth, Wolfgang
Haenel, Mathias
Koehne, Claus-Henning
Lindemann, Hans W.
Berdel, Wolfgang E.
Staib, Peter
Mueller, Martin C.
Proetel, Ulrike
Balleisen, Leopold
Goebeler, Maria-Elisabeth
Dengler, Jolanta
Falge, Christiane
Kanz, Lothar
Burchert, Andreas
Kneba, Michael
Stegelmann, Frank
Pfreundschuh, Michael
Waller, Cornelius F.
Spiekermann, Karsten
Bruemmendorf, Tim H.
Edinger, Matthias
Hofmann, Wolf-Karsten
Pfirrmann, Markus
Hasford, Joerg
Krause, Stefan
Hochhaus, Andreas
Saussele, Susanne
Hehlmann, Ruediger
ANNALS OF HEMATOLOGY, 2015, 94 (12) : 2015 - 2024
[3] Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
Alice Fabarius
Lida Kalmanti
Christian T. Dietz
Michael Lauseker
Sébastien Rinaldetti
Claudia Haferlach
Gudrun Göhring
Brigitte Schlegelberger
Martine Jotterand
Benjamin Hanfstein
Wolfgang Seifarth
Mathias Hänel
Claus-Henning Köhne
Hans W. Lindemann
Wolfgang E. Berdel
Peter Staib
Martin C. Müller
Ulrike Proetel
Leopold Balleisen
Maria-Elisabeth Goebeler
Jolanta Dengler
Christiane Falge
Lothar Kanz
Andreas Burchert
Michael Kneba
Frank Stegelmann
Michael Pfreundschuh
Cornelius F. Waller
Karsten Spiekermann
Tim H. Brümmendorf
Matthias Edinger
Wolf-Karsten Hofmann
Markus Pfirrmann
Joerg Hasford
Stefan Krause
Andreas Hochhaus
Susanne Saußele
Rüdiger Hehlmann
Annals of Hematology, 2015, 94 : 2015 - 2024
[4] IMPACT OF MAJOR ROUTE VERSUS UNBALANCED MINOR ROUTE KARYOTYPES AT DIAGNOSIS ON PROGNOSIS OF CML
Dietz, C. T.
Kalmanti, L.
Fabarius, A.
Lauseker, M.
Haferlach, C.
Schlegelberger, B.
Jotterand, M.
Mueller, M. C.
Haenel, M.
Koehne, C. H.
Goebeler, M. E.
Pfreundschuh, M.
Balleisen, L.
Burchert, A.
Krause, S.
Pfirrmann, M.
Hasford, J.
Hochhaus, A.
Saussele, S.
Hehlmann, R.
HAEMATOLOGICA, 2015, 100 : 325 - 325
[5] Impact of Balanced or Unbalanced Karyotype At Diagnosis On Prognosis of CML: Long-Term Observation From 1346 Patients of the Randomized CML Study IV
Fabarius, Alice
Haferlach, Claudia
Hochhaus, Andreas
Mueller, Martin C.
Hanfstein, Benjamin
Goehring, Gudrun
Schlegelberger, Brigitte
Jotterrand, Martine
Proetel, Ulrike
Hofmann, Wolf-Karsten
Krause, Stefan W.
Einsele, Hermann
Dengler, Jolanta
Falge, Christiane
Kanz, Lothar
Neubauer, Andreas
Kneba, Michael
Stegelmann, Frank
Pfreundschuh, Michael
Waller, Cornelius F.
Spiekermann, Karsten
Lauseker, Michael
Pfirrmann, Markus
Hasford, Joerg
Hehlmann, Ruediger
Saussele, Susanne
BLOOD, 2012, 120 (21)
[6] Mechanisms of resistance in CML.
Sawyers, CL
CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6268S - 6268S
[7] Prognostic factors for allotransplantation in CML.
Copelan, EC
Elder, P
BLOOD, 2005, 106 (11) : 301B - 301B
[8] Unrelated donor BMT for CML.
Dini, G
Lamparelli, T
Rondelli, R
Barbanti, M
Garbarino, L
Lanino, E
Guidi, S
Rosti, G
Alessandrino, EP
Locatelli, F
Marenco, P
Soligo, D
Di Bartolomeo, P
Aversa, F
La Nasa, G
Busca, A
Majolino, I
De Laurenzi, A
Bacigalupo, A
BONE MARROW TRANSPLANTATION, 1998, 21 : S31 - S31
[9] Results of identical twin transplantation for CML.
Lubimova, L
Savchenko, V
Kuzmina, L
Gribanova, E
Mendeleeva, L
Vinogradova, O
BONE MARROW TRANSPLANTATION, 1999, 23 : S61 - S61
[10] The impact of clonal evolution on response to imatinib mesylate (Gleevec) in accelerated phase CML.
O'Dwyer, ME
Mauro, MJ
Kurilik, G
Balleisen, S
Capdeville, R
Druker, BJ
BLOOD, 2001, 98 (11) : 139A - 139A

← 1 2 3 4 5 →